# Crescent Biopharma, Inc. (CBIO) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$153M |
| 2023 | -$39M |
| 2022 | -$47M |
| 2021 | -$63M |
| 2020 | -$52M |
| 2016 | -$32M |
| 2015 | -$13M |
| 2014 | -$11M |
| 2013 | -$11M |
| 2012 | $4M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$25M |
| 2025-03-31 | -$14M |
| 2022-06-30 | -$13M |
| 2021-09-30 | -$17M |
| 2021-06-30 | -$14M |
| 2021-03-31 | -$14M |
| 2020-09-30 | -$14M |
| 2020-03-31 | -$8M |
| 2016-09-30 | -$8M |
| 2015-06-30 | $10M |
| 2015-03-31 | -$7M |
| 2014-06-30 | $8M |
| 2014-03-31 | -$5M |
| 2013-09-30 | -$4M |
| 2013-06-30 | -$3M |
| 2013-03-31 | $458,722 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/CBIO/operating-income)